Remove 2019 Remove Packaging Remove Vaccines
article thumbnail

STAT+: Pharmalittle: Italy probes Pfizer over profit transfers; FDA postpones meeting for OTC birth control pill

STAT

This calls for celebration with a cup of stimulation, and we are opening a new package of Pumpkin Spice for the occasion. The investigation began in February and covers 2017, 2018, and 2019. Autumn, after all, is in full swing. Meanwhile, our ever-growing to-do list requires attention. Sound familiar?

Packaging 246
article thumbnail

NHS expands home-testing kits to detect bowel cancer earlier

Pharma Times

First introduced in April 2019, every two years, the faecal immunochemical test (FIT) will be automatically sent to an additional 830,000 people in England, aged 54 years, to check for blood in a small stool sample, which can be a sign of bowel cancer. Recent data has shown a national uptake increase of the kit from 59.2%

Packaging 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Emergent BioSolutions announces approval from FDA for CYFENDUS vaccine

Pharmaceutical Business Review

Earlier known as AV7909, CYFENDUS vaccine’s efficacy for post-exposure prophylaxis is only based on studies in animal models of inhalational anthrax. Emergent senior vice president, science and development Dr. Kelly Warfield said: “The approval of CYFENDUS vaccine is symbolic of Emergent’s longstanding partnership with the U.S.

article thumbnail

Innovation across the healthcare system is needed to realise the value of medicines

pharmaphorum

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. At Janssen, we strive to improve access to our innovative medicines and vaccines and achieve the best possible outcomes for patients across the world.

article thumbnail

From start to finish – digitising clinical trials

pharmaphorum

Nearly every element of the clinical trial design, data collection, analysis and approvals has been shortened and this helped ensure the swift rollout of safe and effective vaccines.”. In 2019, Formedix collaborated with a UK-based consortium interested in observing early safety data. About the interviewee.

article thumbnail

Breaking through the forecasting fog – 3 trends that will impact critical medicine supply in 2023

pharmaphorum

The same goes for many commodities used in the production process for key medicines, from solvents through to packaging. The recent reversal of China’s “zero Covid” policy, at a time when the country still lacks optimal vaccine coverage, has also created another unknown, in terms of global supply and demand forecasting.

Packaging 105
article thumbnail

Drug advertising: Updated guidance from Health Canada on the distinction between advertising and other activities for health products

Pharma in Brief

An updated version of the Distinction Guidance was first circulated for consultation in 2019. Consultation on the draft guidance ran from July 5, 2019 to September 3, 2019. Distinction Guidance Approach The scope of the Distinction Guidance is now broader.